Risk factors for distal stent graft-induced new entry tear after endovascular repair of thoracic aortic dissection.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
May 2019
Historique:
received: 12 09 2017
accepted: 14 07 2018
pubmed: 8 1 2019
medline: 20 11 2019
entrez: 8 1 2019
Statut: ppublish

Résumé

A review of the literature was conducted for incidence, outcomes, and risk factors for distal stent graft-induced new entry (SINE) after thoracic endovascular aortic repair (TEVAR) of aortic dissection. The review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Seven articles reporting on 1415 patients with thoracic aortic dissection undergoing TEVAR without supplemental distal bare stenting were included. In this cohort, 86 patients were treated for a residual type A aortic dissection and 1329 for a complicated type B aortic dissection. Distal SINE occurred in 112 patients (7.9%). The mean time to identification of distal SINE was 19 ± 7 months. The incidence of distal SINE after TEVAR for type B aortic dissection differed on the basis of whether it was a chronic or acute dissection repair and was, respectively, 12.9% (43/331) and 4.3% (12/273). Successful secondary interventions were performed in 54% of the patients. All the studies analyzing the relationship between distal stent graft oversizing and incidence of distal SINE reported a significantly higher rate of SINE with oversizing. The successful management of complicated descending thoracic aortic dissections by TEVAR is well established. Whereas distal SINE is relatively frequent, if it does occur, the complication can generally be treated with additional TEVAR without a poor outcome. The main determinant of SINE seems to be excessive distal oversizing.

Identifiants

pubmed: 30612824
pii: S0741-5214(18)32256-0
doi: 10.1016/j.jvs.2018.07.086
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1610-1614

Informations de copyright

Copyright © 2018 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Ludovic Canaud (L)

Department of Thoracic and Cardiovascular Surgery, Hôpital A de Villeneuve, Montpellier, France. Electronic address: ludoviccanaud@hotmail.com.

Thomas Gandet (T)

Department of Thoracic and Cardiovascular Surgery, Hôpital A de Villeneuve, Montpellier, France.

Julien Sfeir (J)

Department of Thoracic and Cardiovascular Surgery, Hôpital A de Villeneuve, Montpellier, France.

Baris Ata Ozdemir (BA)

Department of Thoracic and Cardiovascular Surgery, Hôpital A de Villeneuve, Montpellier, France.

Laurence Solovei (L)

Department of Thoracic and Cardiovascular Surgery, Hôpital A de Villeneuve, Montpellier, France.

Pierre Alric (P)

Department of Thoracic and Cardiovascular Surgery, Hôpital A de Villeneuve, Montpellier, France; CHU Montpellier, PhyMedExp, Université de Montpellier, INSERM, CNRS, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH